Kenneth L. Londoner - 25 May 2021 Form 4/A - Amendment Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Kenneth L. Londoner, attorney-in-fact
Issuer symbol
BSGM
Transactions as of
25 May 2021
Net transactions value
+$16,390
Form type
4/A - Amendment
Filing time
03 Sep 2021, 16:45:58 UTC
Date Of Original Report
26 May 2021
Next filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSGM Common Stock Purchase $3,320 +1,000 +0.06% $3.32* 1,646,558 25 May 2021 Direct F1
transaction BSGM Common Stock Purchase $3,300 +1,000 +0.06% $3.30* 1,647,558 25 May 2021 Direct F1
transaction BSGM Common Stock Purchase $3,310 +1,000 +0.06% $3.31* 1,648,558 25 May 2021 Direct F1
transaction BSGM Common Stock Purchase $3,230 +1,000 +0.06% $3.23* 1,649,558 25 May 2021 Direct F1
transaction BSGM Common Stock Purchase $3,230 +1,000 +0.06% $3.23* 1,650,558 25 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purpose of this Amendment is to correct the Transaction Code in column 3 of Table I, which inadvertently used Transaction Code "A" instead of "P".